Chai Discovery Raises $400M to Design Drug Molecules with AI
Another startup promising to speed up drug discovery with generative AI, except this one is already valued at $3.8 billion. Major pharma companies are already paying to use its platform, which sets it apart from the sector's usual hype-first, revenue-later pattern.
practitioners › $400M Series C, $3.8B valuation, announced July 14, 2026, pharma customers already in production.
Chai Discovery →